Mallinckrodt investor relations material

Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. The company's principal categories of products include pain management assets; branded generics; respiratory assets; and specialty distribution services. It serves healthcare organizations such as hospitals, ambulatory surgery centers (ASCs), nursing homes and physicians' offices. The company was founded in 1867 and is based in Dublin, Ireland.